Board of Directors
University of British Columbia
Dr. Judy Illes is Professor of Neurology and Canada Research Chair in Neuroethics at the University of British Columbia. She is Director of the National Core for Neuroethics at UBC, and faculty in the Brain Research Centre and the Vancouver Coastal Health Research Institute. Illes established the International Neuroethics Network in early 2000 and in joining it with the Neuroethics Society formed the International Neuroethics Society. She also created AJOB-Neuroscience, the official journal of INS, and served as its editor for five years before taking on her current role as Senior Editorial Advisor. Illes provides leading guidance to inform policies on major issues of neuroethical importance, including the management of incidental findings in research, multidirectional communication, integration of cross-cultural perspectives on brain health and mental well-being, harm reduction in addiction, and perceptions of risk for experimental interventions for diseases of the central nervous system.
Hank Greely is the Deane F. and Kate Edelman Johnson Professor of Law and Professor, by courtesy, of Genetics at Stanford University. He specializes in ethical, legal, and social issues arising from advances in the biosciences, particularly from neuroscience, genetics and human stem cell research. He directs the Stanford Center for Law and the Biosciences and the Stanford Program on Neuroscience in Society; chairs the California Advisory Committee on Human Stem Cell Research; and serves on the Neuroscience Forum of the Institute of Medicine, the Advisory Council for the National Institute for General Medical Sciences of NIH, the Committee on Science, Technology, and Law of the National Academy of Sciences, and the NIH Multi-Council Working Group on the BRAIN Initiative.
University of Cambridge
Barbara J. Sahakian is Professor of Clinical Neuropsychology at the Department of Psychiatry, University of Cambridge School of Clinical Medicine, and Honourary Consultant Clinical Psychologist, Cambridge University Hospitals NHS Foundation Trust. She is a founding member of the International Neuroethics Society and has an international reputation in the fields of cognitive psychopharmacology, neuroethics, neuropsychology, neuropsychiatry and neuroimaging. She is co-inventor of the CANTAB computerised neuropsychological tests and is probably best known for her research work on cognition and depression, cognitive enhancement using pharmacological treatments, neuroethics and early detection of Alzheimer's disease with over 200 publications in leading scientific journals.
Broad Institute of Harvard / MIT
Steven E. Hyman, M.D. is the director of the Stanley Center for Psychiatric Research at the Broad Institute and is the Harvard University Distinguished Service Professor of Stem Cell and Regenerative Biology. Hyman is the editor of the Annual Review of Neuroscience and the founding president of the International Neuroethics Society.
University of Ottawa
Jennifer Chandler joined the Faculty of Law in 2002, after practicing law with a national firm and serving as a law clerk to the Honorable Mr. Justice John Sopinka of the Supreme Court of Canada. She recently completed her sabbatical as a Visiting Associate Professor at the Centre for Biomedical Ethics, National University of Singapore. She is the Co-Chair of the Law and Ethics Group within the Canadian National Transplant Research Program. She is also a Member of the Ethics Working Group on Organ Transplantation, Trillium Gift of Life Network, Ontario.
Moheb Costandi is a molecular and developmental neurobiologist turned freelance science writer based in London. He writes news stories and feature articles for print and the web, and is the author of the Neurophilosophy blog, hosted by the Guardian.
Duke Law School
Nita Farahany, J.D., Ph.D. is a leading scholar of the ethical, legal, and social implications of biosciences and emerging technologies, particularly those related to neuroscience and behavioral genetics. She is the Director of Duke Science & Society, the Duke MA in Bioethics & Science Policy, and a Professor of Law & Philosophy. In 2010, Farahany was appointed by President Obama to the Presidential Commission for the Study of Bioethical Issues, and continues to serve as a member. Nita has served on the INS board since 2012.
Joseph J. Fins
Weill Cornell Medical College
Joseph J. Fins, M.D., M.A.C.P. is The E. William Davis, Jr. M.D. Professor of Medical Ethics and Chief of the Division of Medical Ethics at Weill Cornell Medical College where he is a Tenured Professor of Medicine, Professor of Medical Ethics in Neurology, Professor of Health Care Policy and Research, and Professor of Medicine in Psychiatry. He the founding Chair of the Ethics Committee of New York-Presbyterian Weill Cornell Medical Center where he is an Attending Physician and the Director of Medical Ethics. A member of the Adjunct Faculty of Rockefeller University and Senior Attending Physician at The Rockefeller University Hospital, he Co-Directs, the Consortium for the Advanced Study of Brain Injury (CASBI) at Weill Cornell and Rockefeller. At Yale Law School, he is the Solomon Center Distinguished Scholar in Medicine, Bioethics and the Law. He is a past president of the American Society for Bioethics and Humanities and former Governor of the American College of Physicians. Dr. Fins is a Member of the Dana Alliance for Brain Initiatives, an elected Member of the Institute of Medicine of the National Academy of Sciences, a Fellow of the American Academy of Arts and Sciences and an Academico de Honor (Honored Academic) of the Real Academia Nacional de Medicina de España (the Royal Academy of Medicine of Spain). His most recent book is Rights Come to Mind: Brain Injury, Ethics & The Struggle for Consciousness published by Cambridge University Press.
American Association for the Advancement of Science
Mark Frankel, Ph.D. is Director, Scientific Responsibility, Human Rights and Law Program at the American Association for the Advancement of Science (AAAS). His areas of interest include research ethics, neuroscience and the law, and social responsibilities of scientists. Mark has served on the INS board since 2012, and as a member of the Annual Meeting Program Committee initiated and organized the first public meeting segment of the INS Annual Meeting in 2013, which he did again in 2014.
Johnson & Johnson
Dr. Husseini K. Manji is the Global Therapeutic Head for Neuroscience at Janssen Research & Development. The major focus of his research has been the investigation of disease- and treatment-induced changes in gene and protein networks that regulate synaptic and neural plasticity in neuropsychiatric disorders. His work has helped to conceptualize these illnesses as genetically-influenced disorders of synaptic and neural plasticity, and has led to the investigation of novel therapeutics for refractory patients. He has also been actively involved in the development of biomarkers to help refine these multifactoral diseases into mechanism-based subcategories to develop targeted therapeutics.
Debra JH Mathews
Johns Hopkins University
Debra JH Mathews, PhD, MA, is the Assistant Director for Science Programs at the Johns Hopkins Berman Institute of Bioethics, with a secondary appointment in the Institute of Genetic Medicine, and Associate Professor in the Department of Pediatrics, in the School of Medicine. Dr. Mathews's academic work focuses on ethics and policy issues raised by emerging biotechnologies, with particular focus on genetics, stem cell science, and neuroscience.
Helen Mayberg, MD is Professor of Psychiatry, Neurology, and Radiology and the Dorothy Fuqua Chair in Psychiatric Imaging and Therapeutics at Emory University. Her research has characterized neural systems mediating major depression and its recovery, defined brain-based illness subtypes to optimize treatment selection, and introduced the first use of deep brain stimulation for treatment resistant patients. She is a member of the National Academy of Medicine and is an active participant in a variety of advisory, editorial and scientific activities across multiple fields in the neurosciences.
Edward F. Rover, J.D. is Chairman and CEO of the Dana Foundation. The Dana Foundation is a private philanthropic organization that supports brain research through grants and educates the public about the successes and potential of brain research. Until December 31, 2003, he was a senior partner at White & Case, L.L.P. in New York where he was active in the representation of tax-exempt organizations. Ed has served on the INS board since 2012.
University of Oxford
Ilina Singh, MA, EdD, is Professor of Neuroscience & Society at the University of Oxford, where she holds a joint appointment between the Department of Psychiatry and the Faculty of Philosophy (Oxford Centre for Neuroethics and Oxford UehiroCentre for Practical Ethics). Her work examines the psychosocial and ethical implications of advances in biomedicine and neuroscience for young people and families.
Paul Root Wolpe
Paul Root Wolpe is the director of the Center for Ethics at Emory, the Asa Griggs Candler Professor of Bioethics, the Raymond F. Schinazi Distinguished Research Chair in Jewish Bioethics, and a professor in the departments of medicine, pediatrics and sociology. He also serves as the first bioethicist for the National Aeronautics and Space Administration, where he formulates policy on bioethical issues and safeguarding research subjects. His teaching and publications range across multiple fields of bioethics and sociology, including death and dying, genetics and eugenics, sexuality and gender, mental health and illness, alternative medicine, and bioethics in extreme environments such as space.
University of Basel
Marcello Ienca is a PhD candidate and research assistant at the Institute of Biomedical Ethics of the University of Basel (Switzerland). He holds degrees in Philosophy and Bioethics from the University of Rome La Sapienza (Italy), the Humboldt University of Berlin (Germany) and the KU Leuven (Belgium). In 2012 he was a Barbara Wengeler visiting scholar at the New York University. His major areas of investigation include the ethical future of pervasive neurotechnology and the social implications of brain-computer interaction. His current research focuses on the ethics of neurosecurity and the use of intelligent assistive technologies in dementia care. In 2015 he was awarded the Arsélio Pato de Carvalho Prize for Social Responsibility in Neuroscience from the University of Porto.